Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Brian D. Roark

Member

Nashville
(615) 742-7753 TEL
(615) 742-0442 FAX

Brian D. Roark

Member

Nashville
(615) 742-7753 TEL
(615) 742-0442 FAX
Nashville
(615) 742-7753 TEL
(615) 742-0442 FAX

Brian is the head of Bass, Berry & Sims' Healthcare Fraud Task Force and concentrates his practice on representing healthcare clients in responding to governmental investigations and defending False Claims Act lawsuits. He has successfully litigated and resolved numerous healthcare fraud matters involving hospitals and health systems, ambulatory surgery centers, hospices, home health companies, drug and alcohol abuse treatment centers, Medicare Advantage companies, and other healthcare providers. 

He serves as an Adjunct Professor of Law at Vanderbilt University, where he teaches Healthcare Fraud and Abuse. He is the Immediate Past Chair of the Tennessee Bar Association's Health Law Section and currently serves on the Bloomberg Law Health Law and Business Editorial Advisory Board. He is ranked in Chambers USA as a top Healthcare Government Investigations and Fraud attorney (Band 1) in Tennessee. According to Chambers USA, interviewees describe Brian as a "'top, eminent guy for investigations work,'" (from Chambers USA 2017) and additionally say "'If I had to refer a client for an investigation, he's the guy I'd go to.'" (from Chambers USA 2016) Brian was selected as a 2014 AHLA Pro Bono Champion for his work handling the trial and appeal of a criminal Medicare fraud case.

Featured Experience

View Experience

News

View More

Representative Experience

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Accolades

Chambers USA — Healthcare: Government Investigations & Fraud (2013-2018)

Best Lawyers in America® — Health Care Law; Litigation: Health Care (2013-2018)

Nashville Medical News "InCharge Healthcare" (2013-2018)

American Health Lawyers Association — Pro Bono Champion (2014)

Mid-South Super Lawyers (2017); "Rising Star" (2013, 2016)

Tennessee Bar Association — Health Care Law Section Executive Council

Bloomberg Law Health Law and Business Editorial Advisory Board (2018)

BNA Health Care Fraud Report — Advisory Board (2013-2018)

North Carolina Law Review — Articles Editor

Law Clerk to James C. Fox, U.S. District Court, Eastern District of North Carolina (1999-2001)

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.